Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Amisulpride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 226Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    LB Pharma's twist on old Sanofi drug passes schizophrenia test
    LB Pharma's twist on old Sanofi drug passes schizophrenia test

    09 Jan 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/lb-pharmas-twist-old-sanofi-drug-passes-schizophrenia-test-teeing-phase-3-push

    FIERCE BIOTECH
    09 Jan 2025
    Share Share
    Eagle Pharma TiP on Pedia IV Amisulpride PONV Ph2/3 at SAMBA 2024
    Eagle Pharma TiP on Pedia IV Amisulpride PONV Ph2/3 at SAMBA 2024

    30 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/30/2872179/0/en/Eagle-Pharmaceuticals-Announces-a-Trial-in-Progress-Presentation-of-Phase-2-3-Study-of-Intravenous-Amisulpride-as-Prevention-of-Postoperative-Nausea-and-Vomiting-in-Pediatric-Patie.html

    GLOBENEWSWIRE
    30 Apr 2024
    Share Share
    Eagle: Sustained Amisulpride PONV Response At ASPAN 2024
    Eagle: Sustained Amisulpride PONV Response At ASPAN 2024

    15 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/15/2862631/0/en/Eagle-Pharmaceuticals-to-Present-Additional-Data-from-Phase-III-Trial-Demonstrating-Sustained-Response-of-Amisulpride-for-the-Rescue-Treatment-of-Postoperative-Nausea-and-Vomiting-.html

    GLOBENEWSWIRE
    15 Apr 2024
    Share Share
    Eagle Pharmaceuticals to Present Abstract on Post-hoc Analysis of Amisulpride
    Eagle Pharmaceuticals to Present Abstract on Post-hoc Analysis of Amisulpride

    06 Dec 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/12/06/2792093/0/en/Eagle-Pharmaceuticals-to-Present-Abstract-on-Post-hoc-Analysis-of-Amisulpride-at-the-77th-PGA-PostGraduate-Assembly-in-Anesthesiology-in-New-York-City.html

    GLOBENEWSWIRE
    06 Dec 2023
    Share Share
    Sunovion and Otsuka Initiate Phase 3 Development of Non-Racemic Amisulpride
    Sunovion and Otsuka Initiate Phase 3 Development of Non-Racemic Amisulpride

    09 Feb 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220105005850/en

    BUSINESSWIRE
    09 Feb 2022
    Share Share
    LB to present Full Results of Dopamine Receptor Occupancy Study of LB-102
    LB to present Full Results of Dopamine Receptor Occupancy Study of LB-102

    07 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211207005911/en

    BUSINESSWIRE
    07 Dec 2021
    Share Share